Stock screener

ACRS

Conviction 100HealthcareScan · Mon, Aug 10, 2026
ACRS$5.90-0.25%
ResistanceSupportVol 14Insider sell
63 bars
Vol MA14 2.57M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Aclaris Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.aclaristx.com
Price5.90
Change-0.25%
Gap+0.17%
Rel volume3.23×
Avg volume2.43M
Avg $ vol13.85M
SMA 205.59
SMA 505.14
SMA 2003.86
Price vs 50+14.72%
Price vs 200+52.90%
MA stackbullish
50/200 cross
Supertrendup · 5.09
RSI (14)58
MACD hist0.04
MACD crossbull · 3d
Stoch %K / %D59 / 63
ADX (14)38
+DI / −DI25 / 11
RSI divergence
MACD divergence
ATR %+6.35%
ADR %6.60%
52w high6.36
52w low1.63
From 52w high-7.31%
Above 52w low+261.66%
New 52w highNo
SqueezeOff
Bollinger width22.61%
%B0.74
Donchian pos58.80%
Donchian high6.52
Donchian low5.01
AVWAP (52w high)6.04
vs AVWAP high-2.33%
AVWAP (52w low)3.76
vs AVWAP low+56.94%
OBV trendFlat
Chaikin MF (20)0.25
Today vs 20d3.23×
Avg vol (14d)2.57M
Avg vol (20d)2.43M
Avg $ vol (20d)13.85M
Market cap867.74M
RS 3m (vs SPY)+15.91%
RS 6m (vs SPY)+60.22%
RS line new highNo
Trend template8/8
Technical rank85.3
1 week+6.60%
1 month+5.65%
3 months+19.57%
6 months+65.13%
1 year+275.48%
YTD+104.69%
P/E-13.37
P/B6.97
P/S110.88
P/FCF-18.37
EPS-0.5300
Div yield
ROE-52.11%
ROA-36.13%
Debt/Eq0.09
Current3.46
EV/EBITDA-11.32
Gross margin41.41%
Net margin-829.58%
Rev growth-58.19%
EPS growth50.84%
Price target12.40
Target upside110.35%
Analyst ratingBuy
Institutional82.70%
Ent. value859.3M
Revenue1.63M
Net income-21.5M
Gross profit435K
Free cash flow-47.22M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out139.66M
Employees73
ListedWed, Oct 7, 2015
Free float98.38M
Float %81.6%
Short interest13.36M
Days to cover6.9d
Short volume58.2%
Squeeze score79 / 100
Next earnings
EPS forecast
Last EPS vs est−$0.15 vs −$0.16
Last surprise+6.3% beat
Setup gradeA+
Conviction100 / 100
Pattern quality
Tech rank85.3 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction
Pattern family
Resistance6.20
Support4.63
Days since event
Candle confirm
News sentiment

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ACRS

All disclosures →
No recent disclosed trades by Congress in ACRS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ACRS · 6 buys · 4 sells

InsiderSideShares
Molineaux Christopher P.
Director · Common Stock · 2026-06-05
Exercise11.58K
Humphries William D.
Director · Common Stock · 2026-06-05
Exercise11.58K
MILANO VINCENT
Director · Restricted Stock Units · 2026-06-05
Exercise11.58K
SCHIFF ANDREW N
Director · Common Stock · 2026-06-05
Exercise11.58K
GOWEN MAXINE
Director · Common Stock · 2026-06-05
Exercise11.58K
GOWEN MAXINE
Director · Restricted Stock Units · 2026-06-05
Exercise11.58K
MILANO VINCENT
Director · Common Stock · 2026-06-05
Exercise11.58K
Mehra Anand
Director · Common Stock · 2026-06-05
Exercise11.58K
SCHIFF ANDREW N
Director · Restricted Stock Units · 2026-06-05
Exercise11.58K
Mehra Anand
Director · Restricted Stock Units · 2026-06-05
Exercise11.58K

SEC filings

EDGAR filings in ACRS · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.